Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thalassemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06440603
What this trial is testing

EKLF Gene Expression in β-thalassemia

Who this might be right for
β-thalassemia
Rofaida Hassan Ahmed 150
Testing effectiveness (Phase 2)Study completedNCT01709032
What this trial is testing

Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia

Who this might be right for
Thalassemia Major With Severe Transfusional Iron Overload
Children's Hospital of Philadelphia 9
Early research (Phase 1)Ended earlyNCT02274233
What this trial is testing

Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia

Who this might be right for
Iron OverloadBeta-Thalassemia
Sideris Pharmaceuticals 24
Post-approval studies (Phase 4)Study completedNCT02342145
What this trial is testing

Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

Who this might be right for
Beta-Thalassemia MajorGraft-versus-host Disease (GVHD)
Zhongming Zhang 205
Early research (Phase 1)Active Not RecruitingNCT03249831
What this trial is testing

A Blood Stem Cell Transplant for Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell DisorderHemoglobinopathies+2 more
City of Hope Medical Center 3
Not applicableUnknownNCT03881917
What this trial is testing

Cystatin c and Beta 2 Microglobulin in Thalassemic Children.

Who this might be right for
Blood Disease
Assiut University 150
Very early researchStudy completedNCT06065189
What this trial is testing

Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With β-thalassemia Major

Who this might be right for
Beta-Thalassemia
Children's Hospital of Fudan University 2
Testing effectiveness (Phase 2)Study completedNCT07292259
What this trial is testing

Combination of Thalidomide and Hydroxyuria in Transfusion Dependent Thalasemmia

Who this might be right for
Transfusion Dependent Beta Thalassemia
Pakistan Blood and Marrow Transplant (PBMT) Group 100
Testing effectiveness (Phase 2)Ended earlyNCT04059406
What this trial is testing

Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx)

Who this might be right for
Beta Thalassemia Intermedia
Ionis Pharmaceuticals, Inc. 29
Not applicableStudy completedNCT01319552
What this trial is testing

Fresh Versus Old Red Blood Cells for Transfusion

Who this might be right for
Iron, Abnormal Blood LevelOther Abnormal Blood Chemistry
Columbia University 14
Not applicableStudy completedNCT07486531
What this trial is testing

Iron Accumulation in Erythrocytes in Patients

Who this might be right for
Beta Thalassemia Major
Ankara City Hospital Bilkent 100
Testing effectiveness (Phase 2)Ended earlyNCT02504619
What this trial is testing

Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseThalassemia
Gamida Cell ltd 1
Not applicableStudy completedNCT00481039
What this trial is testing

Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel

Who this might be right for
Sickle Cell Disease
HaEmek Medical Center, Israel 300
Post-approval studies (Phase 4)Looking for participantsNCT07177300
What this trial is testing

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

Who this might be right for
Sickle Cell Anemia (HbSS)Sickle-β0-thalassemia (HbSβ0)
Children's Hospital Medical Center, Cincinnati 50
Not applicableStudy completedNCT02197845
What this trial is testing

Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators

Who this might be right for
Sickle Cell Disease
Virginia Commonwealth University 353
Post-approval studies (Phase 4)Study completedNCT00105495
What this trial is testing

Efficacy Study in Removing Excess Iron From the Heart

Who this might be right for
Thalassemia MajorHemosiderosis
ApoPharma 60
Post-approval studies (Phase 4)Study completedNCT03117192
What this trial is testing

Zinc Supplementation on Cellular Immunity in Thalassemia Major

Who this might be right for
ThalassemiaSplenectomy; StatusImmunosuppression
Fakultas Kedokteran Universitas Indonesia 58
Not applicableStudy completedNCT03161899
What this trial is testing

Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital

Who this might be right for
Thalassemia Major
Assiut University 246
Not applicableUnknownNCT02761395
What this trial is testing

Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major

Who this might be right for
AL-Hijama in Thalassmia Major
Tanta University 60
Testing effectiveness (Phase 2)Study completedNCT01590628
What this trial is testing

Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell Disease & Thalassemia
Gamida Cell ltd 16
Next Page